ActiTech, L.P. v. LaCore Nutraceuticals, Inc.

CourtUnited States Bankruptcy Court, N.D. Texas
DecidedFebruary 13, 2023
Docket22-03001
StatusUnknown

This text of ActiTech, L.P. v. LaCore Nutraceuticals, Inc. (ActiTech, L.P. v. LaCore Nutraceuticals, Inc.) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, N.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
ActiTech, L.P. v. LaCore Nutraceuticals, Inc., (Tex. 2023).

Opinion

IR Sy EOD QA CLERK, U.S. BANKRUPTCY COURT Se wo ® NORTHERN DISTRICT OF TEXAS 2) SG a 2 eed, ENTERED ey OME fe A THE DATE OF ENTRY IS ON ee Ais SY THE COURT’S DOCKET SN as” The following constitutes the ruling of the court and has the force and effect therein described.

Signed February 13, 2023 7d United States Bankruptcy Judge

IN THE UNITED STATES BANKRUPTCY COURT FOR THE NORTHERN DISTRICT OF TEXAS DALLAS DIVISION IN RE: § § CASE NO. 22-30049 ACTITECH, L.P., § (Chapter 11; Subchapter V) Reorganized Debtor. §

ACTITECH, L.P., and § ACTICHEM, L.P., § Plaintiffs, § § vs. § § ADVERSARY NO. 22-03001 LACORE NUTRACEUTICALS, INC., § MC-GP, LLC, JOHN LABONTE § SHERMAN 301-B, LLC, and SHERMAN § 301-A, LLC, § Defendants. § FINDINGS OF FACT AND CONCLUSIONS OF LAW IN SUPPORT OF JUDGMENT: (A) DECLARING REORGANIZED DEBTOR IS NOT THE OWNER OF CERTAIN

DISPUTED PROPERTY AT SHERMAN, TEXAS MANUFACTURING FACILITY; AND (B) DENYING REQUEST FOR TURNOVER OF SUCH PROPERTY PURSUANT TO SECTION 542

CAME ON FOR TRIAL before this court on October 28, November 4 and 9, and December 13, 2022, the above-referenced Adversary Proceeding (herein so called) filed by two Plaintiffs: (i) one a Chapter 11 Debtor whose plan was confirmed during the pendency of this Adversary Proceeding; and (ii) the other, a company affiliated with the Debtor, which is not itself in bankruptcy (together, the “Plaintiffs”). Plaintiffs request: (a) a declaratory judgment determining that the Reorganized Debtor is the owner of massive amounts of manufacturing equipment inside a 96-acre manufacturing facility at which it previously operated; and (b) an order of turnover of such property, pursuant to section 542 of the Bankruptcy Code. The court heard testimony of seven witnesses—some live and some via declarations or deposition. The court admitted 240 exhibits—many of which were pictures of equipment. Post-hearing briefing was submitted on January 3, 2023. The court has determined that Plaintiffs have failed to meet their burden of proving the Debtor’s ownership of the property in question. The court issues these Findings of Fact and Conclusions of Law in support of this decision, pursuant to Fed. R. Bankr. Pro. 7052. Any Finding of Fact that should more properly be characterized as a Conclusion of Law should be deemed as such, and vice versa. I. INTRODUCTION This Adversary Proceeding presents a disagreement regarding a prepetition Purchase and Sale Agreement and whether certain manufacturing equipment was sold pursuant to it or not. 2 ActiTech, L.P. (“ActiTech,” the “Debtor,” or sometimes the “Reorganized Debtor”) and Actichem, L.P., the Debtor’s sister company (a nondebtor), are Plaintiffs. ActiTech is an operating company, in the business of developing, manufacturing, and selling nutraceuticals, creams, and personal care products. The sister company Actichem, L.P. was formed in the year 2005 as a real estate holding company; it thereafter acquired a large manufacturing facility (more than 500,000 square feet in size) from the iconic, multinational company Johnson & Johnson in Sherman, Texas (the “Sherman Facility”) for the Debtor’s operations. Eventually, the Debtor and Actichem, L.P. decided to sell the Sherman Facility. On June 9, 2021, Actichem, L.P. entered into a Purchase and Sale Agreement with a purchaser. At closing, three additional documents were executed: a Special Warranty Deed; a General Assignment and Bill of Sale; and a Temporary Access and Right of Entry Agreement. The latter document addressed a process and deadlines for the seller’s post-closing removal of certain property that was not sold pursuant to the Purchase and Sale Agreement. Closing on the sale of the Sherman Facility took place July 2, 2021. Around the time of the execution of the closing documents, the new owners of the Sherman Facility entered into a lease agreement with a different company (a company that— similar to the Debtor—was also in the business of manufacturing nutraceuticals), giving it the right of use and possession of the Sherman Facility. Post-closing, a dispute arose regarding the Temporary Access and Right of Entry Agreement. Not only had Actichem, L.P. failed to retrieve the personal property from the Sherman Facility that was not sold pursuant to the Purchase and Sale Agreement, but Plaintiffs were suddenly taking the position that they were 3 entitled to remove certain manufacturing equipment that the purchaser and new tenant believed had been purchased. On January 10, 2022, Debtor filed for bankruptcy to obtain a breathing spell from litigation filed by several creditors. On January 11, 2022, the Plaintiffs filed this Adversary Proceeding against the purchaser under the Purchase and Sale Agreement, the assignees of the purchaser, the new tenant at the Sherman Facility, and the Chief Executive Officer of the new tenant (collectively, the “Defendants”), seeking turnover of much of the manufacturing equipment at the Sherman Facility. Plaintiffs argue that post-closing, the Defendants wrongfully deprived them of retrieving this equipment and other property Plaintiffs left behind. Defendants responded, claiming that all manufacturing equipment was sold pursuant to the Purchase and Sale Agreement, and that Debtor and Actichem, L.P. had themselves breached the Temporary Access and Right of Entry Agreement by failing to timely remove inventory and raw materials (and other random items not included in the Purchase and Sale Agreement—including boxes of the Chief Executive Officer’s personal items) that remained at the Sherman Facility. This Adversary Proceeding mostly boils down to what in fact was purchased and sold, pursuant to the Purchase and Sale Agreement and other transaction documents. II. PARTIES’ STIPULATED FACTS 1. On June 9, 2021, Actichem, L.P. (“Actichem”) [a non-debtor affiliate of the Debtor]1 and MC-GP, LLC (“MC-GP”) executed a Purchase and Sale Agreement whereby

1 The bracketed language has been added by the court to the Parties’ Stipulated Facts for clarity. 4 Actichem, as Seller, agreed to convey to MC-GP, as Purchaser, the manufacturing facility located in Sherman, Texas that Actichem had purchased [many years earlier] from Johnson & Johnson. This property was located at 301 W. FM 1417, Sherman, TX 75090 (the “Sherman Facility”). 2. MC-GP assigned its rights under the Purchase and Sale Agreement to Sherman 301- A, LLC (“Sherman 301-A”) and Sherman 301-B, LLC (“Sherman 301-B”). 3. On June 30, 2021, Sherman 301-A and Sherman 301-B entered into a Commercial Net, Net, Net Lease Agreement with LaCore Nutraceuticals, Inc. (“LaCore Nutraceuticals”), giving it the right of possession to the Sherman Facility. 4. Closing occurred on or about July 2, 2021. On such date, Actichem executed three additional documents: a. A Special Warranty Deed conveying the Sherman Facility to Sherman 301- A and Sherman 301-B; b. A General Assignment and Bill of Sale (the “Bill of Sale”) executed also with Sherman 301-A and Sherman 301-B; and c. A Temporary Access and Right of Entry Agreement (the “Temporary Access Agreement”) also executed with Sherman 301-A and Sherman 301-B. 5. Pursuant to the Agreed Scheduling Order entered by this court on February 24, 2022 [Doc. 38], Rosen Systems, Inc. prepared an audit report of the property located at the Sherman Facility. The “Rosen Report” as defined herein includes the lot numbers, description of property, and pictures of property, all of which were provided by Rosen Systems, Inc.

5 6. Since at least January 31, 2019, an individual named Ms. Elysiann Bishop has had full control of both Actichem and ActiTech. 7. Since at least January 31, 2019, Actichem has had no employees. III. COURT’S ADDITIONAL FINDINGS OF FACT 1. ActiTech, the Debtor, and Actichem, the non-debtor sister company, shared the same accounting department, offices, and resources since at least January 31, 2019. 2.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Alyeska Pipeline Service Co. v. Wilderness Society
421 U.S. 240 (Supreme Court, 1975)
Key Tronic Corp. v. United States
511 U.S. 809 (Supreme Court, 1994)
Pacific Gas & Electric Co. v. G. W. Thomas Drayage & Rigging Co.
442 P.2d 641 (California Supreme Court, 1968)
In Re San Angelo Pro Hockey Club, Inc.
292 B.R. 118 (N.D. Texas, 2003)
Connelly v. Art & Gary, Inc.
630 S.W.2d 514 (Court of Appeals of Texas, 1982)
Jim Walter Window Components v. Turnpike Distribution Center
642 S.W.2d 3 (Court of Appeals of Texas, 1982)
Foust v. Old American County Mutual Fire Insurance Co.
977 S.W.2d 783 (Court of Appeals of Texas, 1998)
Melendez v. State
902 S.W.2d 132 (Court of Appeals of Texas, 1995)
Logan v. Mullis
686 S.W.2d 605 (Texas Supreme Court, 1985)
Reames v. Hawthorne-Seving, Inc.
949 S.W.2d 758 (Court of Appeals of Texas, 1997)
Sonnier v. Chisholm-Ryder Co., Inc.
909 S.W.2d 475 (Texas Supreme Court, 1995)
Fenlon v. Jaffee
553 S.W.2d 422 (Court of Appeals of Texas, 1977)
Alvertis Isbell v. DM Records, Incorporated
774 F.3d 859 (Fifth Circuit, 2014)
Tony Gullo Motors I, L.P. and Brien Garcia v. Nury Chapa
212 S.W.3d 299 (Texas Supreme Court, 2006)
Eun Bok Lee v. Ho Chang Lee
411 S.W.3d 95 (Court of Appeals of Texas, 2013)
Van Valkenburgh v. Ford
207 S.W. 405 (Court of Appeals of Texas, 1918)
Howeth v. Anderson
25 Tex. 557 (Texas Supreme Court, 1860)

Cite This Page — Counsel Stack

Bluebook (online)
ActiTech, L.P. v. LaCore Nutraceuticals, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/actitech-lp-v-lacore-nutraceuticals-inc-txnb-2023.